This document provides the 2017 update of the ESC/EAS Task Force practical clinical guidance for PCSK9 inhibition in patients with ASCVD or familial hypercholesterolemia.
A correction has been published: European Heart Journal, Volume 39, Issue 22, 7 June 2018, Pages 2105
No takes yet. Share an insight, caveat, or question.
Landmesser et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: